Bibliographic Details
Title:
How Can Radiopharmaceutical Therapies Reach Their Full Potential? Improving Dose Reporting and Phase I Clinical Trial Design: Improving Dose Reporting and Phase I Clinical Trial Design
Authors:
Ana P. Kiess , Joseph O'Donoghue , Carlos Uribe , Lisa Bodei , Robert F. Hobbs , Jacob Hesterman , Adam L. Kesner , George Sgouros , Tom Bäck , Manuel Bardies , Alessandro Bartolini , Sören Bentzen , Peter Bernhardt , Ingrid Bloise , Wesley Bolch , Patrik Brodin , Julia Brosch-Lenz , Jacek Capala , Carlo Chiesa , Patricia E. Cole , Marta Cremonesi , Emmanuel Deshayes , Yuni Dewaraja , Roberto Formento-Cavaier , Gerhard Glatting , Harwig Hennekes , Rob Hobbs , Vicki Jardine , Jessica Jensen , Adam Kesner , Mark W. Konijnenberg , Clemens Kratochwil , Phillip H. Kuo , Roberto Maass-Moreno , Michael Morris , Quyen Nguyen , Stig Palm , Neeta Pandit-Taskar , Laurens Raes , Hendrik Rathke , Babak Saboury , Nicola Salem , Lore Santoro , Oliver Sartor , Mike Sathekge , Eileen Sneeden , Lidia Strigari , Scott Tagawa , Amanda Walker , Wolfgang Weber , Fred Wilson , Tahir Yusufaly , Sabine Zitzmann-Kolbe
Contributors:
Supporting clinical sciences, Molecular Imaging and Therapy, Faculty of Medicine and Pharmacy, Nuclear Medicine
Source:
Journal of Clinical Oncology . 42:1734-1737
Publisher Information:
American Society of Clinical Oncology (ASCO), 2024.
Publication Year:
2024
Subject Terms:
Clinical Trials, Phase I as Topic , Research Design , Neoplasms , Clinical Trials, Phase I as Topic/methods , Humans , Radiopharmaceuticals , Neoplasms/radiotherapy , Radiopharmaceuticals/therapeutic use
Document Type:
Article
Language:
English
ISSN:
1527-7755
DOI:
10.1200/jco.23.01241
Access URL:
https://pubmed.ncbi.nlm.nih.gov/38484205 https://biblio.vub.ac.be/vubir /(5ffbaabb-f528-46c5-a90a-4e71782c3e9d).html
Accession Number:
edsair.doi.dedup.....eeb40c16a964a806b5a00b3850cdec2c
Database:
OpenAIRE